450 related articles for article (PubMed ID: 21132122)
1. Challenges and opportunities in dermal/transdermal delivery.
Paudel KS; Milewski M; Swadley CL; Brogden NK; Ghosh P; Stinchcomb AL
Ther Deliv; 2010 Jul; 1(1):109-31. PubMed ID: 21132122
[TBL] [Abstract][Full Text] [Related]
2. Permeation enhancer strategies in transdermal drug delivery.
Marwah H; Garg T; Goyal AK; Rath G
Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
[TBL] [Abstract][Full Text] [Related]
3. Ask the experts: transdermal drug delivery.
Ther Deliv; 2013 Oct; 4(10):1235-8. PubMed ID: 24116908
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in transdermal drug delivery.
Subedi RK; Oh SY; Chun MK; Choi HK
Arch Pharm Res; 2010 Mar; 33(3):339-51. PubMed ID: 20361297
[TBL] [Abstract][Full Text] [Related]
5. Effect of O-acylmenthol on transdermal delivery of drugs with different lipophilicity.
Zhao L; Fang L; Xu Y; Zhao Y; He Z
Int J Pharm; 2008 Mar; 352(1-2):92-103. PubMed ID: 18053661
[TBL] [Abstract][Full Text] [Related]
6. Permeation enhancers in transdermal drug delivery: benefits and limitations.
Kováčik A; Kopečná M; Vávrová K
Expert Opin Drug Deliv; 2020 Feb; 17(2):145-155. PubMed ID: 31910342
[No Abstract] [Full Text] [Related]
7. Vesicular carriers for skin drug delivery: the Pheroid™ technology.
Kilian D; Shahzad Y; Fox L; Gerber M; Du Plessis J
Curr Pharm Des; 2015; 21(20):2758-70. PubMed ID: 25925120
[TBL] [Abstract][Full Text] [Related]
8. Nanomaterial and advanced technologies in transdermal drug delivery.
Rabiei M; Kashanian S; Samavati SS; Jamasb S; McInnes SJP
J Drug Target; 2020 Apr; 28(4):356-367. PubMed ID: 31851847
[TBL] [Abstract][Full Text] [Related]
9. Nanostructured lipid carriers: A potential use for skin drug delivery systems.
Czajkowska-Kośnik A; Szekalska M; Winnicka K
Pharmacol Rep; 2019 Feb; 71(1):156-166. PubMed ID: 30550996
[TBL] [Abstract][Full Text] [Related]
10. Transdermal permeation of drugs with differing lipophilicity: Effect of penetration enhancer camphor.
Xie F; Chai JK; Hu Q; Yu YH; Ma L; Liu LY; Zhang XL; Li BL; Zhang DH
Int J Pharm; 2016 Jun; 507(1-2):90-101. PubMed ID: 27154251
[TBL] [Abstract][Full Text] [Related]
11. Future of the transdermal drug delivery market--have we barely touched the surface?
Watkinson AC; Kearney MC; Quinn HL; Courtenay AJ; Donnelly RF
Expert Opin Drug Deliv; 2016; 13(4):523-32. PubMed ID: 26646399
[TBL] [Abstract][Full Text] [Related]
12. Turning theory into practice: the development of modern transdermal drug delivery systems and future trends.
Perumal O; Murthy SN; Kalia YN
Skin Pharmacol Physiol; 2013; 26(4-6):331-42. PubMed ID: 23921120
[TBL] [Abstract][Full Text] [Related]
13. Low-frequency sonophoresis: application to the transdermal delivery of macromolecules and hydrophilic drugs.
Polat BE; Blankschtein D; Langer R
Expert Opin Drug Deliv; 2010 Dec; 7(12):1415-32. PubMed ID: 21118031
[TBL] [Abstract][Full Text] [Related]
14. Transdermal drug delivery.
Guy RH
Handb Exp Pharmacol; 2010; (197):399-410. PubMed ID: 20217537
[TBL] [Abstract][Full Text] [Related]
15. The use of sonophoresis in the administration of drugs throughout the skin.
Escobar-Chávez JJ; Bonilla-Martínez D; Villegas-González MA; Rodríguez-Cruz IM; Domínguez-Delgado CL
J Pharm Pharm Sci; 2009; 12(1):88-115. PubMed ID: 19470295
[TBL] [Abstract][Full Text] [Related]
16. Overcoming the skin permeation barrier: challenges and opportunities.
Vitorino C; Sousa J; Pais A
Curr Pharm Des; 2015; 21(20):2698-712. PubMed ID: 25925125
[TBL] [Abstract][Full Text] [Related]
17. Chemical Penetration Enhancers for Transdermal Drug Delivery - Success and Challenges.
Ita KB
Curr Drug Deliv; 2015; 12(6):645-51. PubMed ID: 26239423
[TBL] [Abstract][Full Text] [Related]
18. Dermal and transdermal delivery of pharmaceutically relevant macromolecules.
Münch S; Wohlrab J; Neubert RHH
Eur J Pharm Biopharm; 2017 Oct; 119():235-242. PubMed ID: 28647443
[TBL] [Abstract][Full Text] [Related]
19. The transdermal revolution.
Thomas BJ; Finnin BC
Drug Discov Today; 2004 Aug; 9(16):697-703. PubMed ID: 15341783
[TBL] [Abstract][Full Text] [Related]
20. Elastic and Ultradeformable Liposomes for Transdermal Delivery of Active Pharmaceutical Ingredients (APIs).
Souto EB; Macedo AS; Dias-Ferreira J; Cano A; Zielińska A; Matos CM
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
